Cardiogeni Income Statement

Financials in millions GBP. Fiscal year is April - March.

Millions GBP. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2020	FY 2019
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Jul '20 Jul 31, 2020	Jul '19 Jul 31, 2019
Operating Revenue	7.79	0.67	0.66	0.66	0.78
Revenue	7.79	0.67	0.66	0.66	0.78
Revenue Growth	1068.56%	1.52%	-1.10%	-15.15%	8.99%
Cost of Revenue	-	-	-	-	0.17
Gross Profit	7.79	0.67	0.66	0.66	0.61
Selling, General & Admin	4.83	1.18	0.86	3.6	5.53
Other Operating Expenses	-0.06	-0.23	-0.23	-	-
Operating Expenses	4.78	0.95	0.63	3.6	5.53
Operating Income	3.02	-0.28	0.03	-2.94	-4.92
Interest Expense	-	-	-	-0.01	-0.03
Interest & Investment Income	0	-	-	0	0.02
Currency Exchange Gain (Loss)	-0	-	-	-	-
Other Non Operating Income (Expenses)	-1.93	-	-	-	-
EBT Excluding Unusual Items	1.1	-0.28	0.03	-2.95	-4.93
Asset Writedown	-	-	-	-0.13	-0.71
Pretax Income	1.1	-0.28	0.03	-3.08	-5.64
Income Tax Expense	-	-0	-0	-0.7	-3.21
Earnings From Continuing Operations	1.1	-0.28	0.03	-2.39	-2.43
Earnings From Discontinued Operations	-	-	-	0.25	-0.17
Net Income to Company	1.1	-0.28	0.03	-2.13	-2.6
Minority Interest in Earnings	0	0	-	-	-
Net Income	1.1	-0.28	0.03	-2.13	-2.6
Net Income to Common	1.1	-0.28	0.03	-2.13	-2.6
Net Income Growth	-	-	-	-	-

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2020	FY 2019
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Jul '20 Jul 31, 2020	Jul '19 Jul 31, 2019
Free Cash Flow	-3.03	-0.37	-	-0.9	-3.46
Gross Margin	100.00%	100.00%	100.00%	100.00%	78.29%
Operating Margin	38.73%	-42.08%	3.85%	-442.11%	-628.04%
Profit Margin	14.07%	-41.91%	3.86%	-321.20%	-331.74%
Free Cash Flow Margin	-38.85%	-55.29%	-	-135.67%	-441.92%
EBITDA	3.12	-0.18	0.13	-2.17	-3.85
EBITDA Margin	39.98%	-27.35%	19.84%	-	-
D&A For EBITDA	0.1	0.1	0.11	0.76	1.06
EBIT	3.02	-0.28	0.03	-2.94	-4.92
EBIT Margin	38.73%	-42.08%	3.85%	-	-